[Forwarding from BioMed Central.  --Peter Suber.]

BioMed Central announcement
27 April 2010
===================================

University of North Carolina at Greensboro shows support for open access

BioMed Central today announced that the University of North Carolina at
Greensboro has become its newest institutional member.

Founded in 1891, UNCG is one of the original universities in the North
Carolina system of higher education. It now serves nearly 20,000 students on
campus and through a variety of distance learning programs, with an emphasis
on both teaching and research.  The university hosts a number of research
centers including  the Center for Biotechnology, Genomics and Health
Research, the Center for Health of Vulnerable Populations (
http://www.uncg.edu/nur/centerhvp/index.htm), and the Center for Research
Excellence in the Nanobiosciences (http://cren.uncg.edu/).  In 2007, the
Faculty Senate formed the Committee for Scholarly Communications to support
the development of new initiatives, including the development of more open
access publishing by university authors.

Under the auspices of the University Libraries, the university has
established a supporter membership for an initial period of three years.
"As a pioneer in open access publishing, BioMed Central is a great fit for
UNCG's scholarly communications objectives," says Rosann Bazirjian, Dean of
University Libraries. "By becoming an institutional member of BioMed Central
we can express our support for open access publishing in a way that produces
tangible benefits for our faculty and researchers."

Bob Schatz, North American Sales Manager for BioMed Central commented: "One
of our missions is to provide a meaningful publishing outlet for research
being done at universities the size of UNCG. Having the university become an
institutional member helps us carry that message to other similarly-sized
institutions. We see this as a great opportunity for both our
organizations."


Media contact:
Matt McKay
Head of Public Relations
BioMed Central

T: +44 (0) 20 3192 2216
M: +44 (0)7825 257 423
E: [email protected]

Reply via email to